These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22735264)

  • 1. Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization.
    Kim SY; Song KA; Kieff E; Kang MS
    Biochem Biophys Res Commun; 2012 Jul; 424(2):251-6. PubMed ID: 22735264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
    Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
    Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
    Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
    J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
    Shen CL; Huang WH; Hsu HJ; Yang JH; Peng CW
    Antiviral Res; 2019 Apr; 164():123-130. PubMed ID: 30817940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.
    Sears J; Kolman J; Wahl GM; Aiyar A
    J Virol; 2003 Nov; 77(21):11767-80. PubMed ID: 14557661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.
    Boreström C; Forsman A; Rüetschi U; Rymo L
    J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance.
    Kang MS; Lee EK; Soni V; Lewis TA; Koehler AN; Srinivasan V; Kieff E
    J Virol; 2011 Mar; 85(6):2859-68. PubMed ID: 21209116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
    Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1.
    Chen YL; Tsai HL; Peng CW
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1093-9. PubMed ID: 22226960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1.
    Thompson S; Messick T; Schultz DC; Reichman M; Lieberman PM
    J Biomol Screen; 2010 Oct; 15(9):1107-15. PubMed ID: 20930215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.
    Bashaw JM; Yates JL
    J Virol; 2001 Nov; 75(22):10603-11. PubMed ID: 11602702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1.
    Deng Z; Atanasiu C; Zhao K; Marmorstein R; Sbodio JI; Chi NW; Lieberman PM
    J Virol; 2005 Apr; 79(8):4640-50. PubMed ID: 15795250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative assembly of EBNA1 on the Epstein-Barr virus latent origin of replication.
    Summers H; Barwell JA; Pfuetzner RA; Edwards AM; Frappier L
    J Virol; 1996 Feb; 70(2):1228-31. PubMed ID: 8551585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance.
    Dheekollu J; Wiedmer A; Ayyanathan K; Deakyne JS; Messick TE; Lieberman PM
    Cell; 2021 Feb; 184(3):643-654.e13. PubMed ID: 33482082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.